483 Wyeth Pharmaceutical Division of Wyeth Holdings Apr 2018

483 Wyeth Pharmaceutical Division of Wyeth Holdings Apr 2018

Burnell Henry FDA, Omotunde Osunsanmi FDA$119.00 - Available Now

FDA investigators audited the Wyeth Pharmaceutical Division of Wyeth Holdings - Sanford, NC, United States facility and issued inspectional observations (via FDA 483) on 19 Apr 2018.

Product details

  • Category: Biologics
  • Inspection end: 19 Apr 2018
  • Location: Sanford, United States
  • FEI: 1000110954
Add To Cart